Cardiovascular medicine
Progression of cardiac allograft vascular disease as assessed by
serial intravascular ultrasound: correlation to immunological and
non-immunological risk factors
K Pethiga, V Klaussb, B Heubleina, H Mudrab, A Westphala, C Weberb, K Theisenb, A Havericha
a Department
of Thoracic and Cardiovascular Surgery, Division of Surgery,
Hannover Medical School, D-30623 Hannover, Germany, b Department of Internal Medicine, Division of
Cardiology, Klinikum Innenstadt, University of Munich, Munich, Germany
Correspondence to: Dr Pethig Klaus.Pethig{at}thg.mh-hannover.de
Accepted 12 July 2000
OBJECTIVE
To characterise the
severity and progression of cardiac allograft vascular disease (CAVD)
in a large patient cohort, and to evaluate possible immunological
and non-immunological risk factors for progression.
DESIGN
A prospective observational
study using intravascular ultrasound.
SETTING
Two university hospitals.
PATIENTS AND MAIN OUTCOME
MEASURES
Changes in focal plaque, lumen, and total vessel area
(worst site method) were assessed at baseline and after 12.1 (2.8)
months (mean (SD)) of follow up in a cohort of 96 patients (79 male, 17 female; mean age 48.7 (9.6) years; time post-transplant 26.0 (32.4) months).
RESULTS
Overall, the mean (SD)
intimal index of worst sites increased by 6.7 (8.8)%. The increase in
the first 12 months was 7.5 (9.4)%, v 5.9 (8.0)% after the first year (NS). Analysing immunological and
non-immunological risk factors (age, underlying disease, sex, donor
age, immunosuppression, cytomegalovirus, rejection episodes, cholesterol), low density lipoprotein (LDL) cholesterol was found to be the most important predictor of severe progression (as defined by
an increase in intimal index of
15% (p = 0.01).
CONCLUSIONS
Progression of CAVD is
characterised by a continuing increase in intimal hyperplasia,
especially within the first year after heart transplantation. LDL
cholesterol is an important predictor of major progression.
Keywords: heart transplantation; cardiac allograft vasculopathy; intravascular ultrasound
© 2000 by Heart
This article has been cited by other articles:
-
Zakliczynski, M., Nozynski, J., Konecka-Mrowka, D., Krynicka-Mazurek, A., Swierad, M., Maruszewski, M., Przybylski, R., Zembala, M.
(2009). Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: Are they related to the development of cardiac allograft vasculopathy?. J. Thorac. Cardiovasc. Surg.
138: 215-221
[Abstract] [Full Text] -
Yousufuddin, M., Cook, D. J., Starling, R. C., Abdo, A., Paul, P., Tuzcu, E. M., Ratliff, N. B., McCarthy, P. M., Young, J. B., Yamani, M. H.
(2004). Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease. J Am Coll Cardiol
43: 1565-1573
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
